dbo:abstract
|
- Epoxomicin is a naturally occurring selective proteasome inhibitor with anti-inflammatory activity. It was originally discovered in 1992. Injected, it can induce Parkinson's-like symptoms in rats. Derivatives of epoxomicin include carfilzomib. (en)
|
dbo:alternativeName
| |
dbo:iupacName
|
- (2S,3S)-N-((2S,3R)-3-hydroxy-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxobutan-2-yl)-3-methyl-2-((2S,3S)-3-methyl-2-(N-methylacetamido)pentanamido)pentanamide (en)
|
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 4438 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:imagefile
| |
dbp:imagesize
| |
dbp:iupacname
|
- -N--3-methyl-2-pentanamide (en)
|
dbp:othernames
| |
dbp:verifiedfields
| |
dbp:verifiedrevid
| |
dbp:wikiPageUsesTemplate
| |
dct:subject
| |
rdf:type
| |
rdfs:comment
|
- Epoxomicin is a naturally occurring selective proteasome inhibitor with anti-inflammatory activity. It was originally discovered in 1992. Injected, it can induce Parkinson's-like symptoms in rats. Derivatives of epoxomicin include carfilzomib. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |